Endothelin (ET) is a 21-amino acid peptide that is an important component of disease progression in pulmonary arterial hypertension (PAH), a devastating and rapidly progressive condition that leads to right ventricular strain and dysfunction. ET has both acute and chronic effects that are mediated by two receptors—ET
A and ET
B.